Article

Comparative Effects on Fetal Hematopoiesis and Placental Inflammation From Mesenchymal and Hematopoietic Stem Cells as Agents of Transamniotic Stem Cell Therapy (TRASCET) in a Syngeneic Model of Intrauterine Growth Restriction

Published: Reading: 1 min

Abstract

We compared transamniotic stem cell therapy (TRASCET) using either mesenchymal (MSCs) or hematopoietic (HSCs) stem cells on fetal hematopoiesis in a syngeneic model of intrauterine growth restriction (IUGR).

Keywords

Transamniotic Stem Cell TherapyIntrauterine Growth RestrictionFetal HematopoiesisMesenchymal Stem CellsHematopoietic Stem CellsPlacental InflammationMaternal-fetal Medicine

Hashtags

#TRASCET#IUGR#StemCellTherapy#FetalMedicine#PlacentalHealth

This article is published on an external journal. Click below to read the full text.

Read full article ↗
How to cite: GlobalCastMD. Comparative Effects on Fetal Hematopoiesis and Placental Inflammation From Mesenchymal and Hematopoietic Stem Cells as Agents of Transamniotic Stem Cell Therapy (TRASCET) in a Syngeneic Model of Intrauterine Growth Restriction. GlobalCastMD Medical Library. 2024-03-14. https://origin-library.globalcastmd.com/article/8152

Comments (0)